Radiofrequency Ablation During Surgery in Treating Patients With Non-Small Cell Lung Cancer

You may be eligible if

• DISEASE CHARACTERISTICS:
• Diagnosis of malignant non-small cell lung cancer (NSCLC)
• * Intraoperative needle biopsy confirmation allowed
• Resectable disease (stage I or II)
• All tissue to be treated by radiofrequency tumor ablation must be completely contained within boundaries of planned lung resection
• Medically fit to undergo lung resection
• PATIENT CHARACTERISTICS:
• Age:
• Over 18
• Performance status:
• Not specified
• Life expectancy:
• Not specified
• Hematopoietic:
• Not specified
• Hepatic:
• Not specified
• Renal:
• Not specified
• Other:
• Not pregnant or nursing
• PRIOR CONCURRENT THERAPY:
• Biologic therapy:
• No prior or concurrent biologic therapy
• Chemotherapy:
• No prior or concurrent chemotherapy
• Endocrine therapy:
• No prior or concurrent endocrine therapy
• Radiotherapy:
• No prior or concurrent radiotherapy
• Surgery:
• See Disease Characteristics
• Other:
• No other prior therapy for NSCLC